Cannabinoid-based medicines to treat many common diseases.
Cannabis and Cannabinoids: The Basics
The scientific name is Cannabis sativa, although it is usually just called cannabis, or hemp. Cannabis and hemp are actually the same plant but they can be grown to have differences. Cannabis is notorious due to the presence of the chemical delta-9-tetrahydrocannabinol (THC), which is a psychoactive (mind-altering) agent. It is the THC that gets the marijuana user high.
There are many other chemical substances in hemp, 60-100 of which are chemically related to THC but are not THC and are not psychoactive. These chemicals are called cannabinoids.
Clinical research has proven that cannabinoids possess very important pharmaceutical properties and have the potential to be the basis an entirely new class of drugs to treat Metabolic
syndrome diseases including Heart, Cardiovascular, Diabetes, and Rheumatoid Arthritis – by reducing inflammation.
The government of the United States has a patent on the pharmacological use of cannabinoids. The patent itself reads:
“Cannabinoids have been found to have antioxidant properties unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory, and autoimmune diseases.”
Cannabinoids have enormous potential as the basis for new antioxidant and neuroprotectant drugs for the treatment of diseases and conditions including:
Cannabinoids that do not contain THC are better-tolerated treatments for diseases because they are neither toxic nor psychoactive cannabinoids. But THC has certain properties that other cannabinoids don’t have and is appropriate for many diseases because the health benefits of using THC are greater than the adverse effects.
One of the most important non-THC cannabinoids is cannabidiol (CBD), the molecule on which our research is focussed.
Cannabis Therapeutics, Inc. is formed as an emerging Biotechnology company poised to become a world leader in cannabinoid Research and Development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.